Cagrilintide was built to be layered on top of an incretin backbone
Nomes de marcas Tirzepatide comercializado sob a marca Mounjaro
The primary available study, Naessen et al
If you've used a single PDE5 inhibitor and found the response unreliable, incomplete, or too narrow in its effects, a multi-ingredient formulation represents a different clinical approach that may be considered depending on your health profile
Heart rate changes Increased heart rate has been noted as a potential side effect of cagrilintide, consistent with observations across the broader class of weight loss medications
Hypotension and Syncope Adverse reactions related to hypotension (hypotension, orthostatic hypotension, and decreased blood pressure) were reported in 1.3% of WEGOVY-treated adult patients versus 0.4% of placebo-treated patients and syncope was reported in 0.8% of WEGOVY-treated patients versus 0.2% of placebo-treated patients in clinical trials for weight reduction